The impact of Empagliflozin on chronic kidney disease patient regardless of diabetes: A review. Asian Journal of Pharmaceutical and Health Sciences, [S. l.], v. 14, n. 4, p. 3036–3040, 2024. DOI: 10.5530/ajphs.2024.14.73. Disponível em: https://ajphs.com/index.php/ajphs/article/view/39. Acesso em: 31 jan. 2026.